The Economic Times
English EditionEnglish Editionहिन्दी
| 09 March, 2021, 11:57 AM IST | E-Paper

    Vaccine supplies at risk without indemnity for companies: Poonawalla


    Vaccine makers in India have been pushing the govt to include an indemnity clause in their purchase agreement considering the extraordinary situation and urgency caused by the pandemic.

    New Delhi: Supplies of Covid-19 vaccines could be at risk “without indemnity for vaccine makers”, Adar Poonawalla, chief executive officer of Serum Institute of India, said on Thursday. His comment to Reuters comes after ET on Thursday reported that Indian vaccine makers will be held liable for any complications or adverse effects that arise from the administration of their jabs, as the government has not accepted their demand that they be
    Share This Article
    • SAVE

    Sign in to read the full article

    You’ve got this Prime Story as a Free Gift

    Why ?

    • Sharp Insight-rich, Indepth stories across 20+ sectors

    • Access the exclusive Economic Times stories, Editorial and Expert opinion

    • Clean experience with
      Minimal Ads
    • Comment & Engage with ET Prime community
    • Exclusive invites to Virtual Events with Industry Leaders
    • A trusted team of Journalists & Analysts who can best filter signal from noise
    The Economic Times